Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clonally expanded, thyrotoxic effector CD8 + T cells driven by IL-21 contribute to checkpoint inhibitor thyroiditis
Melissa G. Lechner, Zikang Zhou, Aline T. Hoang, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 696
Open Access | Times Cited: 21

Showing 21 citing articles:

Clinical and translational attributes of immune-related adverse events
Karijn P.M. Suijkerbuijk, Mick J M van Eijs, Femke van Wijk, et al.
Nature Cancer (2024) Vol. 5, Iss. 4, pp. 557-571
Closed Access | Times Cited: 38
Advanced oxidation protein products induce apoptosis in thyroid follicular epithelial cells through oxidative stress in Hashimoto’s thyroiditis
Jie Tan, Ruoting Ding, Shitong Yu, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114069-114069
Closed Access | Times Cited: 1
The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction
Ruixi Li, Ting He, Zhichao Xing, et al.
Autoimmunity Reviews (2025) Vol. 24, Iss. 6, pp. 103783-103783
Closed Access | Times Cited: 1
Immune‐related adverse events in non‐small cell lung cancer: Occurrence, mechanisms and therapeutic strategies
Xuwen Lin, Mei Xie, Jie Yao, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 5
Cytokines in cancer
Courtney T.S. Kureshi, Stephanie K. Dougan
Cancer Cell (2024) Vol. 43, Iss. 1, pp. 15-35
Closed Access | Times Cited: 5
A pathologically expanded, clonal lineage of IL-21–producing CD4+ T cells drives inflammatory neuropathy
Maryamsadat Seyedsadr, Madison F. Bang, Ethan C. McCarthy, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 15
Open Access | Times Cited: 4
Insights into autoimmunity and cancer
Xinrui Li, Carmen Ufret-Vincenty, Jacqueline N. Robinson-Hamm, et al.
Nature Immunology (2025)
Closed Access
Systemic immune characteristics predicting toxicity to immune checkpoint inhibitors in patients with advanced breast cancer
Yalong Qi, Hewei Ge, Xiaoying Sun, et al.
Journal of Autoimmunity (2025) Vol. 153, pp. 103423-103423
Open Access
Endocrinopathies Associated With Immune Checkpoint Inhibitor Use
Anupam Kotwal, Randol Kennedy, Nupur Kikani, et al.
Endocrine Practice (2024) Vol. 30, Iss. 6, pp. 584-591
Closed Access | Times Cited: 3
Genetically predicted metabolites mediate the causal associations between autoimmune thyroiditis and immune cells
Yongzhao Chen, Bo Jiang, Cheng Qu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Stocking the toolbox—Using preclinical models to understand the development and treatment of immune checkpoint inhibitor‐induced immune‐related adverse events
Morgan L. Cina, Jessica Shade Venegas, Arabella Young
Immunological Reviews (2023) Vol. 318, Iss. 1, pp. 110-137
Open Access | Times Cited: 4
Integrating Omics into Functional Biomarkers of Type 1 Diabetes
S. Alice Long, Peter S. Linsley
Cold Spring Harbor Perspectives in Medicine (2024) Vol. 14, Iss. 7, pp. a041602-a041602
Closed Access | Times Cited: 1
Non-bacterial cystitis caused by pembrolizumab therapy for adenocarcinoma of the lung: a case report
Caixia Di, Teng Yu, Lei Ni
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Pathogenicity of functionally activated PD-1+CD8+ cells and counterattacks by muscular PD-L1 through IFNγ in myositis
Hirokazu Sasaki, Natsuka Umezawa, Takuji Itakura, et al.
Journal of Autoimmunity (2023) Vol. 142, pp. 103131-103131
Closed Access | Times Cited: 2
A pathologically expanded, clonal lineage of IL-21 producing CD4+ T cells drives Inflammatory neuropathy
Maryamsadat Seyedsadr, Madison F. Bang, Ethan C. McCarthy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Lactoferrin alleviates oxidative stress and endoplasmic reticulum stress induced by autoimmune thyroiditis by modulating the mTOR pathway in the thyroid
Haoran Ding, Jiale Qin, Yixuan Li, et al.
Journal of Endocrinological Investigation (2024)
Closed Access
Targeting immunometabolism to improve cancer therapies
Darby J. Ballard, Liqing Wang, Jugal Kishore Das, et al.
Elsevier eBooks (2024), pp. 95-116
Closed Access
Polyfunctional IL-21+ IFNg+ T follicular helper cells contribute to checkpoint inhibitor diabetes mellitus and can be targeted by JAK inhibitor therapy
Nicole Huang, Jessica Ortega, Katherine C. Kimbrell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course
N. Chanson, Alexandre Galvagni, Manuel Ramos‐Casals, et al.
Lara D. Veeken (2024)
Closed Access
Year in Thyroidology: Basic Science
Graham R. Williams
Thyroid (2023) Vol. 34, Iss. 1, pp. 10-13
Closed Access
Providing Clarity Regarding the Mechanism for Immune Checkpoint Inhibitor–Associated Thyroiditis
Anupam Kotwal
Clinical Thyroidology (2023) Vol. 35, Iss. 11, pp. 443-446
Closed Access
Page 1

Scroll to top